Adial Pharmaceuticals, Inc. (ADIL)
$3.29-6.00%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 1.50
- P/E (TTM)
- -0.20
- Short % float
- 19.20%
- Days to cover
- 4.3
- SI change
- -12.7%
- 1W
- -17.34%
- 1M
- -34.20%
- vs SPY 1W
- -17.20%
- vs SPY 1M
- -36.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ADIL?
- LOPJLB’s latest quantitative signal on Adial Pharmaceuticals, Inc. (ADIL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ADIL in?
- Adial Pharmaceuticals, Inc. (ADIL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Adial Pharmaceuticals, Inc. (ADIL) do?
- Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for …